Cernostics, a Pittsburgh, PA-based cancer diagnostics startup has raised $5 million in funding led by UPMC Enterprises, UPMC’s venture capital arm with participation from Novitas Capital. The company plans to utilize the funding to accelerate the introduction of new diagnostic test for people with an esophageal condition called Barrett’s Esophagus that can lead to cancer. The latest round brings the company’s total funding to date to $12.4M.
http://hitconsultant.net/2016/09/06/cernostics-upmc-enterprises-funding/
Backed by UPMC, Cancer Diagnostics Startup Cernostics Lands $5M